147 related articles for article (PubMed ID: 27139481)
21. Comparison of human cytomegalovirus DNA polymerase activity for ganciclovir-resistant and -sensitive clinical strains.
Kariya M; Mori S; Eizuru Y
Antiviral Res; 2000 Feb; 45(2):115-22. PubMed ID: 10809020
[TBL] [Abstract][Full Text] [Related]
22. Ribonucleotide reductase inhibitors hydroxyurea, didox, and trimidox inhibit human cytomegalovirus replication in vitro and synergize with ganciclovir.
Bhave S; Elford H; McVoy MA
Antiviral Res; 2013 Oct; 100(1):151-8. PubMed ID: 23933116
[TBL] [Abstract][Full Text] [Related]
23. Synergistic effects by combination of ganciclovir and tricin on human cytomegalovirus replication in vitro.
Yamada R; Suda H; Sadanari H; Matsubara K; Tuchida Y; Murayama T
Antiviral Res; 2016 Jan; 125():79-83. PubMed ID: 26640224
[TBL] [Abstract][Full Text] [Related]
24. PD0084430: a non-nucleoside inhibitor of human cytomegalovirus replication in vitro.
Meyer AL; Bruening EE; Dunkle WE; Booth RJ; Steinbaugh BA; Vara Prasad JV
Antiviral Res; 2001 Dec; 52(3):289-300. PubMed ID: 11675146
[TBL] [Abstract][Full Text] [Related]
25. NUDT15-mediated hydrolysis limits the efficacy of anti-HCMV drug ganciclovir.
Zhang SM; Rehling D; Jemth AS; Throup A; Landázuri N; Almlöf I; Göttmann M; Valerie NCK; Borhade SR; Wakchaure P; Page BDG; Desroses M; Homan EJ; Scobie M; Rudd SG; Berglund UW; Söderberg-Nauclér C; Stenmark P; Helleday T
Cell Chem Biol; 2021 Dec; 28(12):1693-1702.e6. PubMed ID: 34192523
[TBL] [Abstract][Full Text] [Related]
26. Activation of 6-Alkoxy-Substituted Methylenecyclopropane Nucleoside Analogs Requires Enzymatic Modification by Adenosine Deaminase-Like Protein 1.
Vollmer KJ; Burns AC; Sauer HE; Williams JD; Komazin-Meredith G; Cardinale S; Butler M; Aron Z; Hussein I; Busch MG; Bowlin TL; Gentry BG
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31332074
[TBL] [Abstract][Full Text] [Related]
27. Oral activity of a methylenecyclopropane analog, cyclopropavir, in animal models for cytomegalovirus infections.
Kern ER; Bidanset DJ; Hartline CB; Yan Z; Zemlicka J; Quenelle DC
Antimicrob Agents Chemother; 2004 Dec; 48(12):4745-53. PubMed ID: 15561852
[TBL] [Abstract][Full Text] [Related]
28. Biosynthesis and half-life of MBX-2168-triphosphate in herpes virus-infected cells.
Sauer HE; Nguyen ML; Williams JD; Bowlin TL; Gentry BG
Antiviral Res; 2020 Mar; 175():104713. PubMed ID: 31968222
[TBL] [Abstract][Full Text] [Related]
29. An in silico-designed flavone derivative, 6-fluoro-4'-hydroxy-3',5'-dimetoxyflavone, has a greater anti-human cytomegalovirus effect than ganciclovir in infected cells.
Fujimoto KJ; Nema D; Ninomiya M; Koketsu M; Sadanari H; Takemoto M; Daikoku T; Murayama T
Antiviral Res; 2018 Jun; 154():10-16. PubMed ID: 29559264
[TBL] [Abstract][Full Text] [Related]
30. Biosynthetic ganciclovir triphosphate: its isolation and characterization from ganciclovir-treated herpes simplex thymidine kinase-transduced murine cells.
Agbaria R; Candotti F; Kelley JA; Hao Z; Johns DG; Cooney DA; Blaese RM; Ford H
Biochem Biophys Res Commun; 2001 Nov; 289(2):525-30. PubMed ID: 11716505
[TBL] [Abstract][Full Text] [Related]
31. The influence of mixed HCMV UL97 wildtype and mutant strains on ganciclovir susceptibility in a cell associated plaque reduction assay.
Eckle T; Jahn G; Hamprecht K
J Clin Virol; 2004 May; 30(1):50-6. PubMed ID: 15072754
[TBL] [Abstract][Full Text] [Related]
32. Rapid detection and quantitation of ganciclovir resistance in cytomegalovirus quasispecies.
Ruiz-Carrascoso G; Romero-Gómez MP; Plaza D; Mingorance J
J Med Virol; 2013 Jul; 85(7):1250-7. PubMed ID: 23592041
[TBL] [Abstract][Full Text] [Related]
33. Pentostatin antagonizes the antiviral activity of MBX-2168 by inhibiting the biosynthesis of the active compound.
Hagen NR; Nguyen ML; Williams JD; Bowlin TL; Gentry BG
Antiviral Res; 2021 Mar; 187():105018. PubMed ID: 33476709
[TBL] [Abstract][Full Text] [Related]
34. Rapid semiquantitative real-time PCR for the detection of human cytomegalovirus UL97 mutations conferring ganciclovir resistance.
Göhring K; Mikeler E; Jahn G; Rohde F; Hamprecht K
Antivir Ther; 2008; 13(3):461-6. PubMed ID: 18572760
[TBL] [Abstract][Full Text] [Related]
35. Rapid simultaneous detection by real-time PCR of cytomegalovirus UL97 mutations in codons 460 and 520 conferring ganciclovir resistance.
Göhring K; Mikeler E; Jahn G; Hamprecht K
J Clin Microbiol; 2006 Dec; 44(12):4541-4. PubMed ID: 17035493
[TBL] [Abstract][Full Text] [Related]
36. Phosphonate analogues of cyclopropavir phosphates and their E-isomers. Synthesis and antiviral activity.
Mhaske SB; Ksebati B; Prichard MN; Drach JC; Zemlicka J
Bioorg Med Chem; 2009 Jun; 17(11):3892-9. PubMed ID: 19410465
[TBL] [Abstract][Full Text] [Related]
37. 2-Acetylpyridine 5-[(dimethylamino)thiocarbonyl]-thiocarbonohydrazone (1110U81) potently inhibits human cytomegalovirus replication and potentiates the antiviral effects of ganciclovir.
Hamzeh FM; Spector T; Lietman PS
Antimicrob Agents Chemother; 1993 Mar; 37(3):602-4. PubMed ID: 8384821
[TBL] [Abstract][Full Text] [Related]
38. Genetic analysis and putative role in resistance to antivirals of the human cytomegalovirus DNA polymerase UL44 processivity factor.
Boutolleau D; Deback C; Bressollette-Bodin C; Conan F; Aït-Arkoub Z; Imbert-Marcille BM; Agut H
Antivir Ther; 2009; 14(6):847-52. PubMed ID: 19812447
[TBL] [Abstract][Full Text] [Related]
39. Selective anti-cytomegalovirus compounds discovered by screening for inhibitors of subunit interactions of the viral polymerase.
Loregian A; Coen DM
Chem Biol; 2006 Feb; 13(2):191-200. PubMed ID: 16492567
[TBL] [Abstract][Full Text] [Related]
40. Multidrug resistance conferred by novel DNA polymerase mutations in human cytomegalovirus isolates.
Scott GM; Weinberg A; Rawlinson WD; Chou S
Antimicrob Agents Chemother; 2007 Jan; 51(1):89-94. PubMed ID: 17043128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
